We aspire to be a dynamic R&D organization by focusing on the best science for those therapies that can deliver true innovation for patients. We will build deep disease area expertise in our core therapeutic areas, strengthen our pipeline and create an inspiring culture.
We will focus on therapeutic areas where we want to be at the cutting edge of innovation: oncology, gastroenterology (GI) and central nervous system (CNS) disease areas where patient need is great, where we can build upon our deep scientific expertise, where we have a strong track record of recent successes, and where we intend to continue discovering innovative new medicines. We also will continue to build upon our global health approach to Vaccines, founded on our dengue and norovirus programs.
Internal Disclaimer Body